Abstract
Background
Rectourethral fistula (RUF) is a rare but significant complication after radical prostatectomy. Many different approaches have been used, but none of them has become the standard of care.
Methods
We present our series of seven patients treated with a transanal rectal advancement flap plus the injection of mesenchymal stem cells, to facilitate the healing of the fistula. Mesenchymal cells were obtained by a new mechanical device known as LIPOGEMS®. We called this technique RAFAL (rectal advancement flap plus adipose lipofilling). In all patients the RUF was a complication of laparoscopic radical prostatectomy. Fistula size ranged from 0.3 to 0.5 cm (median 0.4 cm).
Results
After a median follow-up of 53 months (range 6–163 months), 2 out of 7 patients experienced RUF recurrence. In both cases recurrence was successfully treated by the York-Mason technique in one case and by redo RAFAL in the other. Success rate of RAFAL was 71% (5 of 7). The total success rate of primary RAFAL and redo- RAFAL was 85.7% (6 of 7). No short- or long-term complications were seen.
Conclusions
In our patient population this new procedure was safe and effective.
References
Kitamura H, Tsukamoto T (2011) Rectourinary fistula after radical prostatectomy: review of the literature for incidence, etiology, and management. Prostate Cancer 2011:629105
Giori A, Tremolada C, Vailati R, Navone S, Marfia G et al (2015) Recovery of function in anal incontinence after microfragmented fat graft (LIPOGEMS®) injection: two years follow-up of the first 5 cases. Cell R4(3):e1544
Kirchin V, Page T, KeeganPE Atiemo KOM, Cody JD, McClinton S, Aluko P (2017) Urethral injection therapy for urinary incontinence in women. Cochrane Database Syst Rev Issue 2017:7 (Art. No.: CD003881)
Tremolada C, Versari S (2017) Lipogems: a new device in regenerative medicine providing a natural living implantable bioreactor. Insights Biomed Eng 1:31
Thomas C, Jones J, Jäger W, Hampel C, Thüroff JW, Gillitzer R (2010) Incidence, clinical symptoms and management of rectourethral fistulas after radical prostatectomy. J Urol 183(2):608–612
Chen S, Gao R, Li H, Wang K (2018) Management of acquired rectourethral fistulas in adults. Asian J Urol 5:149–154
Joshi HM, Vimalachandran D, Heath RM, Rooney PS (2011) Management of iatrogenic recto-urethral fistula by transanal rectal flap advancement. Colorectal Dis 13(8):918–920
De Girolamo L, Sartori MF, Arrigoni E, Rimondini L, Albisetti W, Weinstein RL, Brini AT (2008) Human adipose-derived stem cells as future tools in tissue regeneration: osteogenic differentiation and cell-scaffold interaction. Int J Artif Organs 31(6):467–479
Author information
Authors and Affiliations
Contributions
Conception and design: SC, RM, ZM, AA. Acquisition, analysis, or interpretation of data: ZM, SC, AA, BM, RM. Draft of the manuscript: ZM. Critical revision of the manuscript: SC, ZM. Final approval of the version to be published: ZM, RM, AA, DZ, BM, PM, RB, SC. All the authors agree to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Informed consent
Informed consent was obtained from all individual participants included in the study.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Zuin, M., Ruperto, M., Balduino, M. et al. Rectal advancement flap plus adipose lipofilling (RAFAL) for the treatment of rectourethral fistulas after radical prostatectomy. Tech Coloproctol 23, 1003–1007 (2019). https://doi.org/10.1007/s10151-019-02078-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10151-019-02078-8